Eli Lilly and CompanyLLYNYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+22.3%
5Y CAGR+13.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+22.3%/yr
vs +1.4%/yr prior
5Y CAGR
+13.6%/yr
Recent acceleration
Acceleration
+20.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.09B | +36.4% |
| 2024 | $8.13B | +17.2% |
| 2023 | $6.94B | +14.4% |
| 2022 | $6.07B | -1.2% |
| 2021 | $6.14B | +4.6% |
| 2020 | $5.87B | -2.2% |
| 2019 | $6.00B | +4.7% |
| 2018 | $5.73B | -7.2% |
| 2017 | $6.18B | -2.4% |
| 2016 | $6.33B | - |